Post-Viral Fatigue Syndrome: Clinical Trials

4 trials for Post-Viral Fatigue Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 suspended, 1 unknown. 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Suspended 1, Unknown 1
Phase 22Completed 2

Follow Post-Viral Fatigue Syndrome: new trials by email Literature Review of Post-Viral Fatigue Syndrome trials Research Report on Post-Viral Fatigue Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome?
Swimming, Cycling - ME/CFS, Long COVID
Not applicableSuspendedSimon Fraser University502026-02-202026-03-30
Low-dose Naltrexone for Post-COVID Fatigue Syndrome
Low-Dose Naltrexone, Placebo - Post-Viral Fatigue Syndrome
Phase 2CompletedLuis Nacul1602024-01-152026-03-20
Rehabilitation Robot in Patients With Post-Coronavirus Disease (COVID-19) Fatigue Syndrome
Robot rehabilitation - Post-Viral Fatigue Syndrome
Not applicableUnknownPoznan University of Medical Sciences802021-08-012021-11-23
Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection
Ruconest - Post-Viral Fatigue Syndrome, Post-Viral Disorder (Disorder)
Phase 2CompletedIMMUNOe Research Centers402021-01-112025-08-11

Narrower conditions

Fatigue Syndrome, Chronic (4)  ·  COVID-19 (2)  ·  Post-Acute COVID-19 Syndrome (2)  ·  Fibromyalgia (1)  ·  Mast Cell Activation Syndrome (1)  ·  Overtraining Syndrome (1)  ·  Postural Orthostatic Tachycardia Syndrome (1)

Broader conditions

Chronic Disease (4)  ·  Disease Attributes (4)  ·  Encephalomyelitis (4)  ·  Muscular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Nervous System Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Coronaviridae Infections (3)  ·  Coronavirus Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)

Interventions

Naltrexone (1)  ·  Swimming (1)  ·  conestat alfa (1)

Sponsors

IMMUNOe Research Centers (1)  ·  Luis Nacul (1)  ·  Poznan University of Medical Sciences (1)  ·  Simon Fraser University (1)

Countries

Canada (2)  ·  Poland (1)  ·  United States (1)

Top investigators

Alexandra Coates, PhD (1)  ·  Katarzyna Hojan, MD, PhD (1)  ·  Luis Nacul, MD, PhD (1)

Results publications

PMID 36012033, PMID 38740499, PMID 41281561